What is the share price of Gujarat Terce Laboratories Ltd (GUJTERC) today?
The share price of GUJTERC as on 18th July 2025 is ₹49.54. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Gujarat Terce Laboratories Ltd (GUJTERC) share?
The past returns of Gujarat Terce Laboratories Ltd (GUJTERC) share are- Past 1 week: 4.00%
- Past 1 month: -14.94%
- Past 3 months: -15.54%
- Past 6 months: -33.60%
- Past 1 year: 2.34%
- Past 3 years: 60.71%
- Past 5 years: 528.17%
What are the peers or stocks similar to Gujarat Terce Laboratories Ltd (GUJTERC)?
The peers or stocks similar to Gujarat Terce Laboratories Ltd (GUJTERC) include:What is the market cap of Gujarat Terce Laboratories Ltd (GUJTERC) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gujarat Terce Laboratories Ltd (GUJTERC) is ₹37.43 Cr as of 18th July 2025.What is the 52 week high and low of Gujarat Terce Laboratories Ltd (GUJTERC) share?
The 52-week high of Gujarat Terce Laboratories Ltd (GUJTERC) is ₹94.90 and the 52-week low is ₹45.15.What is the PE and PB ratio of Gujarat Terce Laboratories Ltd (GUJTERC) stock?
The P/E (price-to-earnings) ratio of Gujarat Terce Laboratories Ltd (GUJTERC) is -38.19. The P/B (price-to-book) ratio is 5.26.Which sector does Gujarat Terce Laboratories Ltd (GUJTERC) belong to?
Gujarat Terce Laboratories Ltd (GUJTERC) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Gujarat Terce Laboratories Ltd (GUJTERC) shares?
You can directly buy Gujarat Terce Laboratories Ltd (GUJTERC) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Gujarat Terce Laboratories Ltd
GUJTERC Share Price
GUJTERC Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
GUJTERC Performance & Key Metrics
GUJTERC Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-38.59 | 5.26 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
37.08 | 6.54 | 0.76% |
GUJTERC Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
GUJTERC Company Profile
Gujarat Terce Laboratories is engaged in manufacturing of tablets, capsules, and syrup and injection pertaining to the product group pharmaceuticals.
GUJTERC Forecast
GUJTERC Forecasts
GUJTERC
GUJTERC
Income
Balance Sheet
Cash Flow
GUJTERC Income Statement
GUJTERC Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 25.73 | 29.42 | 31.35 | 37.83 | 25.98 | 40.44 | 47.13 | 48.29 | 50.50 | 50.50 | ||||||||||
Raw Materials | 9.37 | 11.03 | 11.84 | 14.28 | 10.25 | 17.88 | 17.70 | 16.65 | 46.31 | 46.31 | ||||||||||
Power & Fuel Cost | 0.05 | 0.06 | 0.08 | 0.10 | 0.10 | 0.16 | 0.11 | 0.17 | ||||||||||||
Employee Cost | 10.64 | 11.93 | 12.82 | 14.81 | 12.63 | 15.49 | 14.38 | 15.11 | ||||||||||||
Selling & Administrative Expenses | 3.57 | 3.82 | 3.85 | 6.02 | 3.93 | 5.97 | 14.57 | 13.44 | ||||||||||||
Operating & Other expenses | 1.58 | 1.85 | 1.96 | 1.66 | 1.03 | -0.48 | 2.18 | 1.34 | ||||||||||||
EBITDA | 0.52 | 0.73 | 0.80 | 0.96 | -1.96 | 1.42 | -1.81 | 1.58 | 4.19 | 4.19 | ||||||||||
Depreciation/Amortization | 0.19 | 0.19 | 0.21 | 0.24 | 0.18 | 0.28 | 0.36 | 0.37 | 0.38 | 0.38 | ||||||||||
PBIT | 0.33 | 0.54 | 0.59 | 0.72 | -2.14 | 1.14 | -2.17 | 1.21 | 3.81 | 3.81 | ||||||||||
Interest & Other Items | 0.31 | 0.23 | 0.25 | 0.29 | 0.39 | 0.40 | 0.72 | 0.68 | 0.42 | 0.41 | ||||||||||
PBT | 0.02 | 0.31 | 0.34 | 0.43 | -2.53 | 0.74 | -2.89 | 0.53 | 3.39 | 3.40 | ||||||||||
Taxes & Other Items | 0.03 | 0.05 | -0.09 | 0.16 | -0.01 | -0.13 | -1.22 | 0.30 | 4.37 | 4.37 | ||||||||||
Net Income | -0.01 | 0.26 | 0.43 | 0.27 | -2.52 | 0.87 | -1.67 | 0.23 | -0.98 | -0.97 | ||||||||||
EPS | -0.01 | 0.35 | 0.58 | 0.36 | -3.40 | 1.17 | -2.25 | 0.31 | -1.31 | -1.31 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
GUJTERC Company Updates
GUJTERC Stock Peers
GUJTERC Past Performance & Peer Comparison
GUJTERC Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Gujarat Terce Laboratories Ltd | -38.19 | 5.26 | — |
Sun Pharmaceutical Industries Ltd | 37.40 | 5.64 | 0.94% |
Cipla Ltd | 22.71 | 3.83 | 1.08% |
Torrent Pharmaceuticals Ltd | 62.06 | 15.63 | 0.91% |
GUJTERC Stock Price Comparison
Compare GUJTERC with any stock or ETFGUJTERC Holdings
GUJTERC Shareholdings
GUJTERC Promoter Holdings Trend
GUJTERC Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
GUJTERC Institutional Holdings Trend
GUJTERC Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
GUJTERC Shareholding Pattern
GUJTERC Shareholding Pattern
GUJTERC Shareholding History
GUJTERC Shareholding History
smallcases containing GUJTERC stock
smallcases containing GUJTERC stock
Looks like this stock is not in any smallcase yet.
GUJTERC Events
GUJTERC Events
GUJTERC Dividend Trend
GUJTERC has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
GUJTERC Dividend Trend
GUJTERC has not given any dividends in last 5 years
GUJTERC Dividends
GUJTERC Dividends
GUJTERC Stock News & Opinions
GUJTERC Stock News & Opinions
Gujarat Terce Laboratories announced that the Annual General Meeting(AGM) of the company will be held on 21 August 2025.Powered by Capital Market - Live
Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 17 July 2025.Powered by Capital Market - Live
Net loss of Gujarat Terce Laboratories reported to Rs 3.39 crore in the quarter ended March 2025 as against net profit of Rs 0.54 crore during the previous quarter ended March 2024. Sales rose 0.90% to Rs 12.32 crore in the quarter ended March 2025 as against Rs 12.21 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 0.98 crore in the year ended March 2025 as against net profit of Rs 0.24 crore during the previous year ended March 2024. Sales rose 4.65% to Rs 50.20 crore in the year ended March 2025 as against Rs 47.97 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales12.3212.21 1 50.2047.97 5 OPM %8.528.19 -7.732.65 - PBDT1.070.93 15 3.770.91 314 PBT0.970.84 15 3.390.54 528 NP-3.390.54 PL -0.980.24 PL Powered by Capital Market - Live
Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 26 May 2025.Powered by Capital Market - Live
Net profit of Gujarat Terce Laboratories rose 50.75% to Rs 1.01 crore in the quarter ended December 2024 as against Rs 0.67 crore during the previous quarter ended December 2023. Sales declined 2.61% to Rs 12.68 crore in the quarter ended December 2024 as against Rs 13.02 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales12.6813.02 -3 OPM %8.606.45 - PBDT1.080.76 42 PBT0.980.67 46 NP1.010.67 51 Powered by Capital Market - Live
Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 4 February 2025.Powered by Capital Market - Live
Net profit of Gujarat Terce Laboratories rose 348.48% to Rs 1.48 crore in the quarter ended September 2024 as against Rs 0.33 crore during the previous quarter ended September 2023. Sales rose 10.56% to Rs 13.30 crore in the quarter ended September 2024 as against Rs 12.03 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales13.3012.03 11 OPM %12.414.49 - PBDT1.600.42 281 PBT1.510.33 358 NP1.480.33 348 Powered by Capital Market - Live
Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 28 October 2024.Powered by Capital Market - Live
Gujarat Terce Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 17 September 2024.Powered by Capital Market - Live
Net Loss of Gujarat Terce Laboratories reported to Rs 0.08 crore in the quarter ended June 2024 as against net loss of Rs 1.31 crore during the previous quarter ended June 2023. Sales rose 10.91% to Rs 11.89 crore in the quarter ended June 2024 as against Rs 10.72 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales11.8910.72 11 OPM %0.67-10.54 - PBDT0.02-1.22 LP PBT-0.07-1.31 95 NP-0.08-1.31 94 Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 5.95%, vs industry avg of 10.46%
Over the last 5 years, market share decreased from 0.02% to 0.01%